Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary Bypass
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The study evaluates the efficacy of intravenous levosimendan treatment started during a
coronary artery bypass operation to wean patients from a heart lung machine.